Changjun Yue
About Changjun Yue
Changjun Yue Global Medical Director
Changjun Yue serves as the Global Medical Director, overseeing medical affairs in Los Angeles, the Asia Pacific region, and Geneva. In this role, Yue is responsible for guiding medical strategies, developing clinical projects, and liaising with global teams to ensure cohesive medical operations. His leadership extends across multiple continents, emphasizing a broad, international approach to medical affairs.
Changjun Yue Education and Expertise
Changjun Yue holds both an MD and a PhD, which provide a strong foundation for his extensive work in medical affairs. His primary areas of expertise are oncology and immunology, where his knowledge contributes significantly to advancing medical research and treatment approaches. Through his comprehensive education and specialized focus, Yue brings precision and depth to his role as Global Medical Director.
Changjun Yue Publications and Research
Changjun Yue has made substantial contributions to the field of medical research, particularly in the area of immunologic factors in breast cancer. His publications reflect a deep understanding of both oncology and immunology, providing valuable insights into the complexities of cancer treatment. His research is critical for driving forward new methodologies and understanding in these fields.
Changjun Yue Presentations at Scientific Conferences
Changjun Yue is an active participant in the scientific community, frequently presenting his research at international scientific conferences. These presentations allow him to share his findings on topics such as immunologic factors in breast cancer with other medical professionals, facilitating knowledge exchange and collaboration within the medical field.
Changjun Yue Expertise in Flow Cytometry and Genomic Profiling
Changjun Yue has extensive experience with flow cytometry and genomic profiling, two critical techniques in the field of medical research. His proficiency with these tools enables him to conduct detailed analyses of cellular properties and genetic information, which are essential for advancing our understanding of various diseases, including cancers.
Changjun Yue Projects on Liquid Biopsy for Solid Tumors
Changjun Yue has been involved in projects focusing on liquid biopsy for solid tumors. This area of research holds promise for less invasive cancer diagnostics and monitoring. By examining circulating tumor DNA and other biomarkers in the blood, Yue's work helps in developing methodologies that could lead to earlier detection and better management of solid tumors.